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ABSTRACT
The aim of this study was to provide an overview of predominant and sporadic methicillin-resistant
Staphylococcus aureus (MRSA) strains in large regions of Austria, and to compare the results with those
from other European countries. In total, 1439 MRSA isolates, collected routinely between January 1996
and June 2006 from ﬁve Austrian federal provinces, were investigated. The isolates were conﬁrmed as
MRSA using mecA/femA multiplex PCR assays. Genes encoding Panton-Valentine leukocidin (PVL),
which are characteristic of community-acquired MRSA, were also detected by PCR. Subtyping was
performed using SmaI macrorestriction digestion of genomic DNA, followed by pulsed-ﬁeld gel
electrophoresis (PFGE) and cluster analysis. Isolates that could not be assigned to clusters were further
analysed by spa typing and/or multilocus sequence typing. The predominant clones detected in Austria
were ST228 (southern German epidemic clone), ST5 (Rhine-Hessen MRSA), the ST8 Austrian clone and
CC8/ST8. Whereas the frequencies of lineages corresponding to ST247, ST45 and ST22 remained
comparably low, an increase in the frequency of lineages corresponding to ST5 and to ST228 was
recorded. Overall, 20 different MRSA types and 321 subtypes were recognised according to PFGE
analysis. The prevalence of different strains varied considerably in the different Austrian regions. When
compared to other European countries, the situation in Austria was most similar to that found in
Germany.
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INTRODUCTION
Since their discovery in 1961, infections with
methicillin-resistant Staphylococcus aureus (MRSA)
have been a growing problem in hospitals world-
wide, as well as in nursing homes and other
medical care facilities [1,2]. These Gram-positive
pathogens are responsible for a wide range of
diseases, e.g., bacteraemia, septic arthritis, endo-
carditis, pneumonia, osteomyelitis, infections of
wounds, bones and joints, and deep abscess
formation [3,4]. Most MRSA strains are multi-
resistant and show susceptibility only to glyco-
peptide antibiotics (e.g., vancomycin), linezolid
and some newly licensed drugs. Insusceptibility
to glycopeptides has been reported from many
parts of the world [5,6], but is so far infrequent.
There are also a few reports concerning linezolid
resistance in MRSA [7].
The prevalence of MRSA varies widely among
regions. In Europe, the prevalence of MRSA
ranges from 0% in Iceland to 1–5% in most
northern European countries, 10–25% in central
and eastern Europe, and >50% in Romania, Malta
and Cyprus [8]. In western Paciﬁc countries, the
MRSA prevalence ranges from 24% in Australia
to c. 70% in Japan and Hong Kong [9–11]. In the
USA, the prevalence is reported to be c. 50% [12].
Increasing frequencies of MRSA are associated
mainly with the emergence and spread of epi-
demic hospital-associated MRSA (haMRSA);
however the emergence and spread of MRSA
strains that are independent of healthcare facil-
ities has also been recorded in the community
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worldwide (community-associated MRSA; caM-
RSA).
In Austria, staphylococci play a major role in
hospital-acquired infections, and are the most
common cause of bacterial infection among in-
patients. The incidence of MRSA infection ranged
between 0.85 and 2.42 ⁄ 1000 inpatients during
1994–1998 [13], and the proportion of MRSA
among all S. aureus isolates increased from 8.8%
in 1999-2002 [1] to 13.7% (mean value) in 2002–
2005 [14]. To date, no data concerning the occur-
rence and distribution of the epidemic haMRSA
genotypes in Austria have been published. The
aim of the present study was to provide an
overview of the genotypes present throughout
Austria, with a special focus on the federal
provinces of Carinthia, Salzburg, Upper Austria
(UA), Lower Austria (LA) and Vienna. The
situation in Austria was also compared to that
in other European countries.
MATERIALS AND METHODS
Bacterial isolates
Methicillin-resistant S. aureus isolates received at the National
Reference Centre (Linz, Austra) between January 1996 and
June 2006 were collected. In total, 1790 isolates that the
senders considered to be MRSA were received, but the
isolates were not collected systematically. The isolates were
sent from 45 hospitals, 11 physicians and two private
laboratories in Carinthia, Salzburg, UA, LA, Styria and
Vienna. The isolates were grouped into six regions for the
analyses, based on the regional geographical conditions and
socio-economic characteristics: i.e., Carinthia, Salzburg, Salz-
kammergut (which is mainly the southern part of UA),
central UA, eastern UA ⁄western LA and central ⁄ eastern
LA ⁄Vienna (Viennese region). The different areas started
sending isolates at different times (see Results). Isolates from
Styria and from northwestern UA were not included in the
geographical analysis as the numbers were too low. Isolates
were derived from patients with either MRSA infection or
colonisation. For the present study, only primary isolates
were investigated.
Table 1 lists the reference strains used; these belonged to
ten clonal lineages and either formed part of the Harmony
collection of European epidemic MRSA [15] or were kindly
provided by H. de Lencastre (Instituto de Tecnologia Quimica
e Biologica, Laboratory of Molecular Genetics, Oeiras,
Portugal) or W. Witte (Robert-Koch-Institute, Wernigerode,
Germany).
Molecular typing strategy
All isolates were subjected to cluster analysis of SmaI mac-
rorestriction patterns (see below) and compared with major
epidemic clonal lineages of haMRSA (Table 1). For compar-
isons, the clusters were named according to multilocus
sequence types (STs). Isolates that could not be attributed to
clusters were further typed by means of spa sequence typing
and BURP (based upon repeat patterns) analysis, as described
below, and ⁄ or by means of multilocus sequence typing
(MLST) at the German National Reference Centre for Staph-
ylococci (Robert-Koch-Institute, Wernigerode Branch, Ger-
many) or the UK Staphylococcus Reference Laboratory (Centre
for Infections, Health Protection Agency, London, UK). Previ-
ous investigations have revealed that SmaI macrorestric-
tion ⁄ cluster analysis, spa typing and MLST analysis yield
highly concordant results [16,17] that allow isolates to be
attributed to clonal lineages and clonal complexes.
Table 1. Reference strains of meth-
icillin-resistant Staphylococcus aureus
(MRSA)
MLST Straina Isolate no. Reference ⁄ source
ST228 Southern German EMRSA 131 ⁄ 98 HC
ST228 Southern German EMRSA 1155-2 ⁄ 98 HC
ST247 Northern German EMRSA 134 ⁄ 93 HC
ST247 Northern German EMRSA ⁄Belgium EC-1 97S96 HC
ST5 Rhine-Hessen EMRSA 2387 ⁄ 00 RKI
ST5 Rhine-Hessen EMRSA ⁄Belgium EC-3 97S101 HC
ST45 Berlin EMRSA 1150 ⁄ 93 RKI
ST45 Berlin EMRSA ⁄Belgium EC-2 97S99 HC
ST22 Barnim MRSA 1678 ⁄ 96 RKI
ST22 Barnim MRSA ⁄UK-EMRSA-15 90 ⁄ 10685 HC
ST239 Vienna EMRSA 635 ⁄ 93 RKI
ST239 ⁄ 241 Greece 1 3680 HC
ST239 ⁄ 241 UK-EMRSA-1 NCTC 11939 HC
ST239 HUSA304—Hungary (ATCC BAA-39) [33,44,54], ITB
ST239 HU25—Brazil [38,55], ITB
ST239 2HK—Czech Republic [56], ITB
ST239 GRE18—Greece [40], ITB
ST239 CPS22—Portugal [57], ITB
ST241 TAW9—Taiwan [36], ITB
ST36 Finland E5 75916 HC
ST36 UK-EMRSA-16 96 ⁄ 32010 HC
ST8 France A 162 HC
ST8 France B 97121 HC
ST254 Hanover area EMRSA 1000 ⁄ 93 RKI
MLST, multilocus sequence typing; HC, HARMONY collection of European epidemic MRSA; ITB, Instituto de
Tecnologia Quimica e Biologica Laboratory of Molecular Genetics, Oeiras, Portugal; RKI, Robert-Koch-Institute
Wernigerode Branch, Germany.
aIsolates used as reference strains in Fig. 1 are shown in bold type
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DNA isolation
Pure cultures were grown on TSS (trypticase soy agar contain-
ing sheep blood 5% v ⁄v) plates (bioMe´rieux, Marcy l’Etoile,
France) overnight at 37C in an atmosphere containing CO2
5% v ⁄v. A pipette-tip of bacterial culture was resuspended in
phosphate-buffered saline, centrifuged at 12 000 g for 1 min
and then resuspended in lysis buffer (8 mM Tris-HCl, pH 7.5,
containing lysostaphin 20 mg ⁄L, and proteinase K 20 mg ⁄L)
for 1 h at 37C. After boiling for 5 min, DNA was extracted
from 200 lL of bacterial suspension, using a QIAamp DNA
Mini kit according to the manufacturer’s instructions (Qiagen,
Hilden, Germany), and eluted in 200 lL of distilled water.
PCR and restriction digestion
Identiﬁcation as MRSA was conﬁrmed using a multiplex PCR
for the femA and mecA genes [18,19]. The primers used [20,21]
yielded fragments of 533 bp (mecA) and 467 bp (femA). In brief,
the multiplex PCR comprised 200 lM dNTPs, 1.5 mM MgCl2,
1· reaction buffer (Applied Biosystems, Foster City, CA, USA),
1.25 U of AmpliTaq DNA Polymerase (Applied Biosystems),
and 1 lM of each primer, with 30 cycles of 95C for 1 min,
57C for 1 min and 72C for 1 min.
Coagulase gene polymorphism was detected following
digestion with AluI, as described by Schwarzkopf [22], using
the primers described by Goh et al. [23]. Fragment lengths
depend on the polymorphism, and vary from 654 to 1059 bp.
PCR conditions comprised 95C for 3 min, followed by 30
cycles of 95C for 30 s, 57C for 1 min and 72C for 2 min, with
a ﬁnal extension at 72C for 5 min.
A third PCR was performed as described by Lina et al. [24]
to detect genes encoding Panton–Valentine leukocidin (PVL),
which is characteristic of caMRSA strains.
SmaI macrorestriction digestion, pulsed-ﬁeld gel
electrophoresis (PFGE) and cluster analyses
All isolates were investigated by SmaI macrorestriction diges-
tion and subsequent PFGE according to Bannerman et al. [25]
and the recommendations of the EU Harmony project [15].
Analysis of PFGE band patterns was according to the
guidelines of Tenover et al. [26]. Cluster analyses of SmaI
macrorestriction patterns were performed using the UPGMA
(unweighted pair-group method with arithmetic mean) clus-
tering algorithm and the Dice correlation coefﬁcient (Finger-
printing II Software; BioRad, Hercules, CA, USA). Clusters
were deﬁned using a similarity cut-off value of 70%.
spa typing
Methicillin-resistant S. aureus isolates that could not be attrib-
uted to clusters according to their PFGE patterns were further
analysed by spa typing. Bacterial DNA was prepared as
described on the Ridom Bioinformatics website (http://
www.ridom.de/doc/Ridom_spa_sequencing.pdf). Sequenc-
ing was performed using an ABI Prism 310 Genetic Analyzer
(Applied Biosystems). Ridom StaphType software (Ridom
GmbH, Wu¨rzburg, Germany) was used for subsequent spa
sequence analysis.
RESULTS
Distribution and occurrence of MRSA types
The number of regions and hospitals submitting
isolates, as well as the overall number of isolates,
increased steadily from the year 2000 onwards.
A mean of 30 isolates ⁄ year was received in
1996–2001, and this increased to a mean of
416 isolates ⁄ year in the last 2.5 years of the study.
Table 2 shows that the year in which the MRSA
strains with a higher incidence were detected
was, in most cases, earlier than that in which
sporadically emerging strains were detected.
Macrorestriction digestion of the genomic DNA
and subsequent PFGE revealed 321 different band
patterns (MRSA subtypes), which were assigned
Table 2. Occurrence of types and
subtypes of methicillin-resistant
Staphylococcus aureus (MRSA)
between January 1996 and June 2006
MRSA type n %
No.
subtypes
No. of PVL-positive
MRSA
Year ﬁrst
detected
CC5 ⁄ ST228 (southern German) 709 49 131 0 1996
CC5 ⁄ ST5 (Rhine-Hessen) 155 11 30 7 1999
CC8 ⁄ ST8 Austrian clone 143 10 34 0 1996
CC8 ⁄ ST8 130 9 23 22 2000
CC8 ⁄ ST247 (northern German) 73 5 11 0 1996
CC22 ⁄ ST22 (Barnim) 56 4 13 1 2002
CC30 ⁄ ST36 (Finland E5) 50 4 13 0 1998
CC8 ⁄ ST239 (Vienna) 21 2 7 0 1996
CC8 ⁄ ST239 ⁄ 241 17 1 17 0 1996
CC45 ⁄ ST45 (Berlin) 12 0.8 7 0 1996
CC30 ⁄ ST30 12 0.8 11 10 2003
ST80 12 0.8 9 11 2001
ST152 11 0.8 4 11 2002
ST778 10 0.7 1 0 2003
CC8 ⁄ ST254 (Hanover) 8 0.6 4 0 1996
Not known 6 0.4 – 0 2006
Not typeable 5 0.3 – 0 2006
CC8 ⁄ ST72 3 0.2 2 0 2004
ST12 2 0.1 1 0 2002
ST777 2 0.1 1 2 2004
ST97 1 0.1 1 0 2005
ST250 1 0.1 1 0 2004
In total 1439 321 64
CC, clonal complex; ST, sequence type; PVL, Panton–Valentine leukocidin.
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to 20 MRSA types as described in Materials and
methods.
The present study analysed 1439 primary
MRSA isolates from among the 1790 isolates
received; the remaining 351 isolates comprised
methicillin-susceptible S. aureus (n = 182), repeat
isolates (n = 35), specimens other than S. aureus
(n = 59), untyped isolates from 1996–2000
(n = 69), or others (n = 6). Almost half (49%) of
the isolates investigated belonged to ST228
(southern German epidemic strain), which was
found throughout the entire study period in all
Austrian regions (Table 2). The diversity of sub-
types of this strain was extraordinarily high (131
subtypes; Table 2). The remaining 51% of isolates
included several MRSA strains that also occur in
other countries, e.g., ST5 (Rhine-Hessen MRSA),
CC8 ⁄ ST8, ST247 (northern German epidemic
strain), ST22 (Barnim-MRSA), ST36 (Finland E5),
ST239 (Vienna epidemic strain) and
CC8 ⁄ ST239 ⁄ 241.
One particular pattern was related to isolates
attributed to ST8 and ST247, but was clearly
separated (Fig. 1). As isolates with this pattern
had a wide dissemination, this pattern was
designated the ‘Austrian clone’. These isolates
belonged to spa types t190 and t594, and BURP
analysis attributed this pattern to ST8. This was
conﬁrmed for 12 representative isolates by spa
typing and ⁄ or MLST.
The other MRSA types identiﬁed (Table 2) had
a prevalence of <1% and occurred sporadically.
A further 0.4% of all isolates (n = 6) could not be
subtyped by coagulase polymorphism and PFGE
because they yielded previously unknown band
patterns. In addition, it was not possible to
(sub)type 0.3% of all isolates (n = 5), because
no bands were detectable after SmaI macrore-
striction digestion (in three independent experi-
ments).
PVL-positive MRSA
The presence of the genes encoding PVL was
investigated in 672 randomly chosen MRSA iso-
lates. Of these, 64 were PVL-positive, and most of
these belonged to ST8, followed by ST80, ST152,
and ST30 (Table 2).
Predominant MRSA strains in Austria
The data in Tables 2 and 3 show that the most
predominant MRSA types in Austria were
ST228, ST5, ST8 Austrian clone, CC8 ⁄ ST8,
ST247, ST22 and ST36. Fig. 2 summarises the
occurrence of these strains between January 1996
and June 2006. ST228 was predominant through-
out this period, although its proportion seemed
to decrease slightly. ST247 emerged between
2000 and 2003. ST36 accounted for a signiﬁcant
proportion of isolates between 2000 and 2004,
after which it nearly disappeared. ST5 steadily
increased in frequency, beginning in 2003 and
continuing to the end of the study. The fre-
quency of occurrence of ST22 also increased after
2004, albeit to a lesser extent. CC8 ⁄ ST8 remained
at a constant frequency of 9–13% after 2003. The
incidence of the ST8 Austrian clone ﬂuctuated
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Fig. 1. Dendrogram illustrating the
similarity of SmaI macrorestriction
proﬁles of the Austrian clone and
other methicillin-resistant Staphylo-
coccus aureus strains. • Indicates ref-
erence strains, with the isolate
numbers shown in Table 1. The spa
types of the reference strains were as
follows: northern German, t051;
CC8 ⁄ ST8, t008; Vienna epidemic
strain, t037; southern German, t001;
Rhine-Hessen, t002; and Barnim,
t032.
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Table 3. Predominant methicillin-resistant Staphylococcus aureus (MRSA) strains in several regions of Austriaa
Carinthia 2000 (%) 2001 (%) 2002 (%) 2003 (%) 2004 (%) 2005 (%) 2006 (%) Total (%)
CC5/ST228 0 15 (44) 24 (42) 41 (66) 120 (78) 189 (80) 92 (87) 481 (73)
CC8/ST247 6 (100) 18 (53) 29 (51) 11 (18) 4 (3) 1 (0.4) 0 69 (11)
Others 0 1 (3) 4 10 (16) 29 (19) 46 (19) 14 (13) 104 (16)
Total 6 (100) 34 (100) 57 (100) 62 (100) 153 (100) 236 (100) 106 (100) 654 (100)
Salzburg 2002 (%) 2003 (%) 2004 (%) 2005 (%) 2006 (%) Total (%)
CC5 ⁄ ST228 11 (69) 0 2 (100) 18 (35) 6 (29) 37 (41)
CC5 ⁄ ST5 2 (13) 0 0 5 (10) 2 (10) 9 (10)
CC8 ⁄ ST8 0 0 0 10 (19) 3 (14) 13 (14)
CC22 ⁄ ST22 0 0 0 7 (14) 5 (24) 12 (13)
Others 3 (18) 0 0 12 (23) 5 (24) 20 (22)
Total 16 (100) 0 2 (100) 52 (100) 21 (100) 91 (100)
Salzkammergut 2002 (%) 2003 (%) 2004 (%) 2005 (%) 2006 (%) Total (%)
CC5 ⁄ ST228 0 0 9 (33) 4 (10) 1 (6) 14 (15)
CC5 ⁄ ST5 0 0 7 (26) 26 (62) 16 (89) 49 (53)
CC8 ⁄ ST8 0 0 4 (15) 6 (14) 0 10 (11)
CC8 ⁄ ST239 5 (100) 0 6 (22) 3 (7) 0 14 (15)
Others 0 0 1 (4) 3 (7) 1 (5) 5 (5)
Total 5 (100) 0 27 (100) 42 (100) 18 (100) 92 (100)
Central UA 1997 (%) 1998 (%) 1999 (%) 2000 (%) 2001 (%) 2002 (%) 2003 (%) 2004 (%) 2005 (%) 2006 (%) Total (%)
CC5 ⁄ ST228 3 (60) 28 (71) 10 (71) 14 (67) 12 (44) 8 (40) 11 (37) 5 (12) 8 (12) 12 (11) 111 (30)
CC5 ⁄ ST5 0 0 1 (7) 0 0 1 (5) 0 3 (7) 11 (16) 34 (30) 50 (13)
Austrian clone 2 (40) 2 (5) 0 4 (19) 1 (4) 4 (20) 4 (13) 4 (9) 9 (13) 5 (5) 35 (9)
CC8 ⁄ ST8 0 0 0 1 (5) 1 (4) 2 (10) 8 (27) 16 (37) 21 (30) 26 (23) 75 (20)
CC22 ⁄ ST22 0 0 0 0 0 1 (5) 2 (7) 5 (12) 11 (16) 13 (12) 32 (9)
CC30 ⁄ ST36 0 3 (8) 0 2 (10) 11 (41) 3 (15) 3 (10) 5 (12) 1 (1) 5 (5) 33 (9)
Others 0 5 (13) 3 (21) 0 2 (7) 1 (5) 2 (6) 5 (12) 8 (12) 15 (14) 41 (11)
Total 5 (100) 38 (100) 14 (100) 21 (100) 27 (100) 20 (100) 30 (100) 43 (100) 69 (100) 110 (100) 377 (100)
Eastern UA/western LA 2001 (%) 2002 (%) 2003 (%) 2004 (%) 2005 (%) 2006 (%) Total (%)
CC5 ⁄ ST228 2 (100) 0 2 (13) 10 (21) 1 (17) 3 (17) 18 (19)
Austrian clone 0 6 (86) 9 (60) 26 (55) 5 (83) 12 (67) 58 (61)
CC30 ⁄ ST36 0 1 (14) 2 (13) 8 (17) 0 0 11 (12)
Others 0 0 2 (13) 3 (6) 0 3 (17) 8 (8)
Total 2 (100) 7 (100) 15 (100) 47 (100) 6 (100) 18 (100) 95 (100)
Viennese region 1996 (%) 2000 (%) 2001 (%) 2003 (%) 2004 (%) 2005 (%) 2006 (%) Total (%)
CC5 ⁄ ST228 15 (56) 5 (100) 0 3 (100) 0 15 (43) 2 (11) 40 (38)
CC5 ⁄ ST5 0 0 1 (50) 0 5 (36) 1 (3) 5 (26) 12 (11)
Austrian clone 4 (15) 0 0 0 2 (14) 6 (17) 5 (26) 17 (16)
CC8 ⁄ ST8 0 0 0 0 3 (21) 2 (6) 1 (5) 6 (6)
CC8 ⁄ ST239 ⁄ 241 2 (7) 0 0 0 0 4 (11) 0 6 (6)
CC8 ⁄ ST239 1 (4) 0 1 (50) 0 0 0 0 2 (2)
Others 5 (18) 0 0 0 4 (29) 7 (20) 6 (32) 22 (21)
Total 27 (100) 5 (100) 2 (100) 3 (100) 14 (100) 35 (100) 19 (100) 105 (100)
aYear not shown indicates that no samples were received.
CC, clonal complex; ST, sequence type; UA, Upper Austria; LA, Lower Austria.
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Fig. 2. Predominant methicillin-
resistant Staphylococcus aureus strains
in Austria between January 1996
and June 2006.
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between 3% and 40%; from 2002, its mean
incidence was 11%.
Predominant MRSA strains at the regional level
One particular MRSA strain was predominant in
each of Carinthia, Salzkammergut and eastern
UA ⁄western LA (Table 3). In Carinthia, 73%
(mean value) of all isolates belonged to ST228.
From 2001, the frequency of this strain increased
from 44% to 87%. ST247 accounted for 100% of
isolates in the year 2000, probably as a result of an
outbreak.
In the Salzkammergut, the proportion of ST5
isolates increased from 26% in 2004 to 89% in
2006, and this strain accounted for 53% of all
isolates in the Salzkammergut region during the
study period (Table 3). Other strains that oc-
curred relatively frequently in this region were
ST228 (which decreased from 33% in 2004 to 6%
in 2006), ST239 and CC8 ⁄ ST8 (Table 3).
In eastern UA ⁄western LA, the ST8 Austrian
clone was clearly predominant, accounting for
61% (mean value) of all isolates from this region
from 2002 (Table 3). Two other MRSA strains
showed a somewhat higher incidence in this
region, namely ST228 (19%) and ST36 (12%).
The Salzburg, central UA and Viennese regions
showed a higher diversity of strains, and no
single MRSA strain was predominant (Table 3).
However, some strains seemed to occur prefer-
entially in these regions (e.g., ST22 in Salzburg,
and ST239 and ST239 ⁄ 241 in the Viennese region).
DISCUSSION
The data presented above give an overview of the
MRSA types currently circulating in Austria, and
allow a comparison with other European coun-
tries. Relatively few isolates were received and
typed between 1996 and 2000, but the number of
isolates steadily increased from 2001 onwards,
and each MRSA isolate was routinely typed.
Thus, the recent data are more comprehensive
than those collected earlier.
The increasing number of isolates reﬂects an
increasing awareness of the importance of MRSA
epidemiology, and the need to increase efforts to
detect and resolve outbreaks of MRSA infection as
early as possible. However, under-reporting is
still widespread, and the large differences in the
numbers of isolates from the different regions do
not necessarily represent differences in MRSA
prevalence among these regions. Nevertheless,
the large number of isolates received from Carin-
thia and central UA over a long period of time
probably provides a fairly accurate view of the
epidemiological situation in at least these two
regions.
As reported in other European countries,
c. 80% of all isolates belonged to only four MRSA
types. ST228 was the largest group and repre-
sented 50% of all isolates; ST5, ST8 Austrian clone
and CC8 ⁄ ST8 each accounted for c. 10% of all
isolates. If ST247, ST22 and ST36 are also
included, these seven lineages account for 92%
of all Austrian isolates. A similar range of MRSA
types can be found in certain countries, e.g.,
Germany [27], Switzerland [28], Poland [29] and
France [30].
ST228 has been predominant in Carinthia since
2003, increasing in proportion during every
subsequent year. Interestingly, ST228 isolates
have also been reported from Italy [31] and
Slovenia (http://www.harmony-microbe.net). How-
ever, some differences in the spa types suggest
that the ST228 lineages in Austria, Italy and
Slovenia have developed independently of each
other, perhaps because of the natural boundary of
the Alps. Indeed, in Austria, several subtypes of
ST228 were found only, or almost only, in
Carinthia. An explanation for this might again
be the natural boundary of the Alps, which
separates Carinthia from all ﬂanking Austrian
federal provinces and countries. These subtypes
indicate that genomic rearrangements in MRSA
belonging to ST228 are quite frequent. However,
some subtypes remained rare and appear to have
a limited capacity for spread (93 of 131 subtypes
were isolated only once or twice).
Also of interest was the occurrence of MRSA
type ST247 (northern German epidemic strain) in
Carinthia during 2000–2003. Of the 73 isolates of
that type analysed, 69 were from Carinthia, and
66 were from an outbreak in a single hospital. A
single subtype predominated, with 86% of the
ST247 isolates in the hospital belonging to this
subtype, which is rare in other Carinthian hospi-
tals. This suggests that the outbreak caused by
this strain must have been associated with intra-
hospital transfer. ST247 has been reported from
many European countries [32,33], being frequent
during the 1990s, but becoming more rare subse-
quently [34].
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ST5 was found in many regions of Austria,
except eastern UA ⁄western LA, with a remark-
able increase in frequency during the past 3 years
(Fig. 2). A comparable rise has been reported in
Germany [35]. The situation in the Salzkammer-
gut region was unusual in that it was dominated
by ST5, with only four MRSA types (ST5, ST239,
ST228, CC8 ⁄ ST8) representing 96% of all isolates.
As in Carinthia, this could be explained by the
geographical location (partly bordered by the
Alps), and also by the fact that it is a less
important business location ⁄ industrial area than
central UA or Vienna (see below), and thus has a
low migration rate.
In eastern UA ⁄western LA, 93% of all isolates
belonged to only three MRSA strains, i.e., the ST8
Austrian clone, ST228 and ST36. The predominant
ST8 Austrian clone was similar, but not identical,
to isolates attributed to ST8 and ST247. Whereas
the Austrian clone mainly occurred in central UA,
eastern UA ⁄western LA and the Viennese region,
the CC8 ⁄ ST8 clone was predominant in central
UA (as was the Austrian clone), Salzburg and the
Salzkammergut. ST247 was found mainly in
Carinthia.
In contrast to Carinthia, the Salzkammergut
and eastern UA ⁄western LA, the central UA and
Viennese regions showed a high diversity of
MRSA types. The latter two regions attract many
workers and business employees, which might
result in a high migration rate, a high population
density and, especially in Vienna, citizens of very
diverse origins.
Notable MRSA strains in the Viennese region
were ST239, which also occurred in the Salzkam-
mergut, and ST239 ⁄ 241, which occurred only in
the Viennese region at a signiﬁcant frequency
(6%). Both strains are very similar, since ST241
(Taiwan clone) is a single-locus variant of ST239
(Hungarian clone) [36]. MRSA isolates of lineage
ST239 were reported as ‘Vienna’ MRSA in the
mid-1990s as part of an outbreak of nosocomial
infections in Vienna [37]. This clone has been
recorded worldwide, particularly in Brazil [38],
Portugal [39], Greece [40] and Mongolia [41], and
also in countries neighbouring Austria, i.e., Ger-
many [42], the Czech Republic [43] and Hungary
[44]. The low prevalence of the Vienna MRSA
clearly distinguishes Austria, as well as Germany
and Switzerland, from southern European coun-
tries, e.g., Italy, Portugal and Greece, and middle
European countries, e.g., the Czech Republic and
Hungary, all of which have a high prevalence of
this strain.
Eastern UA ⁄western LA and central UA
were the only regions with a noteworthy fre-
quency (9–12%) of ST36. However, in eastern
UA ⁄western LA, this strain was detected only
between 2002 and 2004, and its prevalence in
central UA seems to have been decreasing since
2001. If this trend continues, ST36 might disap-
pear from Austria. However, this clone is very
similar to the epidemic MRSA clone UK-EMRSA-
16, which is the second most frequent epidemic
MRSA clone in the UK, with both clones being
assigned to ST36 in the MLST database (http://
www.mlst.net). Comparison of the PFGE patterns
reveals no differences between these two strains,
and the present study found that they had
identical coagulase patterns.
Compared to the other Austrian regions, ST22
occurred most frequently in Salzburg, perhaps
indicating a possible epidemiological link
between Salzburg and Germany, where ST22 is
the most frequent epidemic MRSA clone [27,35].
During the 2 years in which this strain was
detected (2005 and 2006), its percentage rose from
14% to 24%, but this period was too short to
conﬁrm a genuine upward tendency.
With respect to MRSA, Switzerland shows
little similarity to Austria, with 29.5% of all
MRSA isolates belonging to lineage ST45 (Bel-
gium EC-2 strain, Berlin epidemic strain), 17.7%
to ST247 (Belgium EC-1 strain; related to the
northern German epidemic strain and the Iberian
clone [28]), 9% to a Switzerland-speciﬁc strain,
and 35% to 62 sporadically occurring PFGE types
[28].
It has been reported that MRSA strains express-
ing PVL are emerging community-acquired patho-
gens, such that PVL-positiveMRSA strains are also
referred to as caMRSA [45]. However, other char-
acteristics, e.g., resistance patterns and the pres-
ence of type IV and V SCCmec elements, as well as
the patient’s history, also deﬁne caMRSA [46]. The
present study revealed PVL-positive MRSA
isolates belonging to seven different STs, with the
most frequent corresponding to ST80, ST152, ST30
and ST8. ST80 seems to be one of the most
widespread caMRSA strains in Europe [46–52].
ST30 is also spread widely throughout European
countries [47,50–52] and in the Paciﬁc region
[47,48]. In contrast, ST152 seems to be restricted to
only a few countries [48,50,53].
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In conclusion, the high number of MRSA
isolates in the present study means that the data
can serve as a basis for infection control studies in
the separate Austrian regions. The pattern of
clonal lineages of haMRSA observed was similar
to that observed in Germany, although the fre-
quency distributions differed. The lineages of
PVL-positive MRSA were also largely in accord.
The reasons for the differences in MRSA strains
among particular countries, despite worldwide
dissemination of epidemic haMRSA, are still
unexplored.
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